Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Bovine S100A8 ELISA Kit (AC3544)
Cat.#: ASET-2133
Specifications
Description Bovine S100A8 ELISA Kit allows for the in vitro quantitative determination of bovine S100A8 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Bovine Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1338 Human FOXO1A ELISA Kit (AC2749) Quantitative inquiry ASET-1141 Human Dio3 ELISA Kit (AC2552) Quantitative inquiry ASET-1033 Human NGF ELISA Kit (AC2444) Quantitative inquiry ASET-1868 Human CASK ELISA Kit (AC3279) Quantitative inquiry ASET-1343 Human Netrin 4 ELISA Kit (AC2754) Quantitative inquiry ASET-1705 Rat Galanin ELISA Kit (AC3116) Quantitative inquiry ASET-1704 Human Tyrosine Hydroxylase ELISA Kit (AC3115) Quantitative inquiry ASET-1341 Chicken Acetylcholinesterase ELISA Kit (AC2752) Quantitative inquiry ASET-2543 Human Neuropilin 1 ELISA Kit (AC3954) Quantitative inquiry ASET-1706 Rat Visfatin ELISA Kit (AC3117) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket